Advancing the neuroimaging diagnosis and understanding of mitochondrial disorders

Neurotherapeutics. 2024 Jan;21(1):e00324. doi: 10.1016/j.neurot.2024.e00324. Epub 2024 Feb 1.

Abstract

Mitochondrial diseases, a diverse and intricate group of disorders, result from both nuclear DNA and mitochondrial DNA malfunctions, leading to a decrease in cellular energy (ATP) production. The increasing understanding of molecular, biochemical, and genetic irregularities associated with mitochondrial dysfunction has led to a wider recognition of varying mitochondrial disease phenotypes. This broadening landscape has led to a diverse array of neuroimaging findings, posing a challenge to radiologists in identifying the extensive range of possible patterns. This review meticulously describes the central imaging features of mitochondrial diseases in children, as revealed by neuroimaging. It spans from traditional imaging findings to more recent and intricate diagnoses, offering insights and highlighting advancements in neuroimaging technology that can potentially guide a more efficient and accurate diagnostic approach.

Keywords: Mitochondrial dysfunction; Mitochondrial neuroimaging; Mitochondrial syndromes.

Publication types

  • Review

MeSH terms

  • Child
  • DNA, Mitochondrial / genetics
  • Humans
  • Mitochondria
  • Mitochondrial Diseases* / diagnostic imaging
  • Mitochondrial Diseases* / genetics
  • Neuroimaging / methods
  • Phenotype

Substances

  • DNA, Mitochondrial